Biologic Drugs for Rheumatoid Arthritis in the Context of Biosimilars, Genetics, Epigenetics and COVID-19 Treatment

Rheumatoid arthritis (RA) affects around 1.2% of the adult population. RA is one of the main reasons for work disability and premature retirement, thus substantially increasing social and economic burden. Biological disease-modifying antirheumatic drugs (bDMARDs) were shown to be an effective therap...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cells
Main Authors: Bonek, Krzysztof, Roszkowski, Leszek, Massalska, Magdalena, Maslinski, Wlodzimierz, Ciechomska, Marzena
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2021
Assuntos:
Review
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7914976/
https://ncbi.nlm.nih.gov/pubmed/33557301
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells10020323
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares